Related references
Note: Only part of the references are listed.The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice
Lei Zhang et al.
EUROPEAN HEART JOURNAL (2012)
Systemic Markers of Interferon-γ-Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease
Eva Ringdal Pedersen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study
Petri Niinisalo et al.
ANNALS OF MEDICINE (2010)
Urinary biomarkers involved in type 2 diabetes: a review
Agnes Matheson et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Yutang Wang et al.
NATURE MEDICINE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
D. Fuchs et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry
Oivind Midttun et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2009)
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography -: A Randomized controlled trial
Marta Ebbing et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: The Health 2000 study
P. Niinisalo et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Urinary proteomic biomarkers on coronary artery disease
Lukas U. Zimmerli et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season
M. Pertovaara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-γ contributes to medial immunoprivilege
Madison C. Cuffy et al.
JOURNAL OF IMMUNOLOGY (2007)
Update on microalbuminuria as a biomarker in renal and cardiovascular disease
Hiddo J. Lambers Heerspink et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Monitoring tryptophan metabolism in chronic immune activation
K Schröcksnadel et al.
CLINICA CHIMICA ACTA (2006)
Nitration and inactivation of IDO by peroxynitrite
H Fujigaki et al.
JOURNAL OF IMMUNOLOGY (2006)
Gamma interferon: a central mediator in atherosclerosis
MLA Leon et al.
INFLAMMATION RESEARCH (2005)
Kidney in early atherosclerosis
AR Chade et al.
HYPERTENSION (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry
A Biroccio et al.
ANALYTICAL BIOCHEMISTRY (2005)
Tryptophan and the immune response
JR Moffett et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Immune activation and degradation of tryptophan in coronary heart disease
B Wirleitner et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry
PI Holm et al.
CLINICAL CHEMISTRY (2003)
Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease
WP Battisti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Endogenous kynurenines as targets for drug discovery and development
TW Stone et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
CP Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
EUROPEAN HEART JOURNAL (2000)
Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue
AM Hansen et al.
REDOX REPORT (2000)